4201 - 4210 of 6258 Results
Title
Year
- The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein2017OPENTitle: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 110Issue #:Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006Best OA location URL: https://doi.org/10.1016/j.nbd.2017.11.006Citation Count: 44
- Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains2018OPENTitle: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 309Issue #:Start Page: 91End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016Citation Count: 46
- N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine2024OPENTitle: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholineJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.97228.3Best OA location URL: https://doi.org/10.7554/elife.97228.3Citation Count: 1
- Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study2021OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
- Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity2018OPENTitle: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27392Citation Count: 139
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/294951Citation Count: 27
- Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation2025OPENTitle: Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 766End Page: 779Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328567Best OA location URL: https://doi.org/10.1177/1877718x251328567Citation Count: 0
-
OPENTitle: Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tauJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 3Start Page: 932End Page: 943Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa021Best OA location URL: https://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdfCitation Count: 71
- Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice2021OPENTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://escholarship.org/uc/item/35j6s17tCitation Count: 9
- Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner2025OPENTitle: Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent mannerJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2025.1554059Best OA location URL: https://doi.org/10.3389/fonc.2025.1554059Citation Count: 0